(Ak6) Vest Therapy
Payments companies reported to CMS as associated with (Ak6) Vest Therapy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Ak6) Vest Therapy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Ak6) Vest Therapy
These are the largest totals companies reported as associated with (Ak6) Vest Therapy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Harmohinder Kochar | Houston, TX | Pulmonary Disease | $527.01 |
| Jose Melendez | Houston, TX | $504.48 | |
| Ashraf Mansour | Elizabeth, NJ | Internal Medicine | $496.30 |
| Usha Thalody | Elizabeth, NJ | Internal Medicine | $496.29 |
| Carlos Remolina | Linden, NJ | Pulmonary Disease | $483.94 |
| Anubha Sinha | Perth Amboy, NJ | Pulmonary Disease | $434.30 |
| Neil Chowdhry | Perth Amboy, NJ | Internal Medicine | $428.52 |
| Abdul Shahin | Brooklyn, NY | Physician Assistant | $411.45 |
| Dmitriy Yadgarov | Forest Hills, NY | Pulmonary Disease | $406.28 |
| Irina Zolotarevskaya | Rego Park, NY | Pulmonary Disease | $406.23 |
Prescribed (Ak6) Vest Therapy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.